KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueDividends payablesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strategy (MSTR) Cash & Equivalents (2016 - 2025)

Strategy (MSTR) has disclosed Cash & Equivalents for 16 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 5937.91% to $2.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, up 5937.91% year-over-year, with the annual reading at $2.3 billion for FY2025, 5937.91% up from the prior year.
  • Cash & Equivalents hit $2.3 billion in Q4 2025 for Strategy, up from $54.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.3 billion in Q4 2025 to a low of $1.1 million in Q4 2021.
  • Historically, Cash & Equivalents has averaged $135.0 million across 5 years, with a median of $6.2 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: crashed 96.91% in 2023 and later soared 5937.91% in 2025.
  • Year by year, Cash & Equivalents stood at $1.1 million in 2021, then skyrocketed by 552.41% to $7.0 million in 2022, then soared by 565.68% to $46.8 million in 2023, then decreased by 18.58% to $38.1 million in 2024, then skyrocketed by 5937.91% to $2.3 billion in 2025.
  • Business Quant data shows Cash & Equivalents for MSTR at $2.3 billion in Q4 2025, $54.3 million in Q3 2025, and $2.0 million in Q2 2025.